Biohaven Pharmaceutical Holding Company Ltd.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Biohaven Pharmaceutical Holding Company Ltd.
Quantité totale PI 28
Rang # Quantité totale PI 52 974
Note d'activité PI 1,9/5.0    10
Rang # Activité PI 89 684
Symbole boursier BHVN (nyse)
ISIN VGG111961055
Capitalisation 4,499M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

5 0
2 0
21 0
0
 
Dernier brevet 2023 - Prodrugs of riluzole and their m...
Premier brevet 2013 - Pro-drugs of riluzole and their ...

Derniers inventions, produits et services

2022 Invention Prodrugs of riluzole and their method of use. Pharmaceutical compositions of the invention includ...
Invention Pharmaceutical compositions of cgrp inhibitors and methods of their use. Provided is pharmaceutic...
2021 Invention Compositions for improved delivery of cgrp inhibitors. Provided is a pharmaceutical formulation i...
Invention Compositions for improved delivery of cgrp inhibitors. Provided is a pharmaceutical composition i...
Invention Methods of treating pulmonary injury with cgrp inhibitors. Provided is a method for treating COVI...
Invention Oral fast-dispersing dosage form of rimegepant. Provided is a fast-dispersing dosage form for ora...
2020 Invention Intranasal pharmaceutical compositions of cgrp inhibitors. Provided is pharmaceutical composition...
Invention Formulation for oral delivery of proteins, peptides and small molecules with poor permeability. ...
Invention Formulation for oral delivery of proteins, peptides and small molecules with poor permeability. T...
Invention Cgrp antagonists for treating migraine breakthrough. Disclosed are methods of treating breakthrou...
2019 Invention Prodrugs of cgrp antagonists. Disclosed are prodrugs of CGRP antagonists, methods of treating CGR...
Invention Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis....
Invention Use of riluzole oral disintigrating tablets for treating diseases. Disclosed are methods of treat...
Invention Rimegepant for cgrp related disorders. Disclosed are methods of treating CGRP related disorders, ...
2018 Invention Use of riluzole prodrugs to treat ataxias. Disclosed are methods of treating ataxia by administer...
2017 Invention Prodrugs of lanicemine and their method of use. Pharmaceutical compositions of the invention incl...
Invention Acyl benzo[d]thiazol-2-amine and their methods of use. Disclosed are acyl benzo[d]thiazol-2-amine...
Invention Use of riluzole, riluzole prodrugs or riluzole analogs with immunotherapies to treat cancers. Dis...
Invention Use of glutamate modulating agents with immunotherapies to treat cancer. Disclosed are methods of...
2016 Invention Amine prodrugs of pharmaceutical compounds. Disclose are amine prodrugs and methods of synthesis ...
Invention Prodrugs riluzole and their method of use. Pharmaceutical compositions of the invention include s...
Invention Riluzole prodrugs and their use. Pharmaceutical compositions of the invention include substituted...
2015 Invention Sublingual formulation of riluzole. Disclosed is sublingual administration of riluzole. In partic...
Invention Sublingual administration of riluzole. Disclosed is sublingual administration of riluzole. In par...